Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Luteinizing Hormone-releasing Hormone Analogs Market Growth 2022-2028

  • LP 4891162
  • 97 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Luteinizing Hormone-releasing Hormone Analogs will have significant change from previous year. According to our (LP Information) latest study, the global Luteinizing Hormone-releasing Hormone Analogs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Luteinizing Hormone-releasing Hormone Analogs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Luteinizing Hormone-releasing Hormone Analogs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Luteinizing Hormone-releasing Hormone Analogs market, reaching US$ million by the year 2028. As for the Europe Luteinizing Hormone-releasing Hormone Analogs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Luteinizing Hormone-releasing Hormone Analogs players cover AbbVie, AstraZeneca, Ferring, and TerSera Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Luteinizing Hormone-releasing Hormone Analogs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Leuprorelin

Goserelin

Taltirelin

Histrelin

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie

AstraZeneca

Ferring

TerSera Therapeutics

Takeda

LIVZON

Ipsen

Sanofi

Endo

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Luteinizing Hormone-releasing Hormone Analogs by Country/Region, 2017, 2022 & 2028

2.2 Luteinizing Hormone-releasing Hormone Analogs Segment by Type

2.2.1 Leuprorelin

2.2.2 Goserelin

2.2.3 Taltirelin

2.2.4 Histrelin

2.2.5 Other

2.3 Luteinizing Hormone-releasing Hormone Analogs Sales by Type

2.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

2.3.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Type (2017-2022)

2.4 Luteinizing Hormone-releasing Hormone Analogs Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Luteinizing Hormone-releasing Hormone Analogs Sales by Application

2.5.1 Global Luteinizing Hormone-releasing Hormone Analogs Sale Market Share by Application (2017-2022)

2.5.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Application (2017-2022)

3 Global Luteinizing Hormone-releasing Hormone Analogs by Company

3.1 Global Luteinizing Hormone-releasing Hormone Analogs Breakdown Data by Company

3.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Company (2020-2022)

3.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Company (2020-2022)

3.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Company (2020-2022)

3.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Company (2020-2022)

3.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company (2020-2022)

3.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Company

3.4 Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Product Location Distribution

3.4.2 Players Luteinizing Hormone-releasing Hormone Analogs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region

4.1 World Historic Luteinizing Hormone-releasing Hormone Analogs Market Size by Geographic Region (2017-2022)

4.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Geographic Region

4.2 World Historic Luteinizing Hormone-releasing Hormone Analogs Market Size by Country/Region (2017-2022)

4.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Country/Region

4.3 Americas Luteinizing Hormone-releasing Hormone Analogs Sales Growth

4.4 APAC Luteinizing Hormone-releasing Hormone Analogs Sales Growth

4.5 Europe Luteinizing Hormone-releasing Hormone Analogs Sales Growth

4.6 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Growth

5 Americas

5.1 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country

5.1.1 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)

5.1.2 Americas Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)

5.2 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Type

5.3 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region

6.1.1 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2017-2022)

6.1.2 APAC Luteinizing Hormone-releasing Hormone Analogs Revenue by Region (2017-2022)

6.2 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Type

6.3 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Luteinizing Hormone-releasing Hormone Analogs by Country

7.1.1 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)

7.1.2 Europe Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)

7.2 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Type

7.3 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs by Country

8.1.1 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)

8.2 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Type

8.3 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Luteinizing Hormone-releasing Hormone Analogs

10.3 Manufacturing Process Analysis of Luteinizing Hormone-releasing Hormone Analogs

10.4 Industry Chain Structure of Luteinizing Hormone-releasing Hormone Analogs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Luteinizing Hormone-releasing Hormone Analogs Distributors

11.3 Luteinizing Hormone-releasing Hormone Analogs Customer

12 World Forecast Review for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region

12.1 Global Luteinizing Hormone-releasing Hormone Analogs Market Size Forecast by Region

12.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Region (2023-2028)

12.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Type

12.7 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.1.3 AbbVie Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.2.3 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Ferring

13.3.1 Ferring Company Information

13.3.2 Ferring Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.3.3 Ferring Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ferring Main Business Overview

13.3.5 Ferring Latest Developments

13.4 TerSera Therapeutics

13.4.1 TerSera Therapeutics Company Information

13.4.2 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.4.3 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 TerSera Therapeutics Main Business Overview

13.4.5 TerSera Therapeutics Latest Developments

13.5 Takeda

13.5.1 Takeda Company Information

13.5.2 Takeda Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.5.3 Takeda Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Takeda Main Business Overview

13.5.5 Takeda Latest Developments

13.6 LIVZON

13.6.1 LIVZON Company Information

13.6.2 LIVZON Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.6.3 LIVZON Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 LIVZON Main Business Overview

13.6.5 LIVZON Latest Developments

13.7 Ipsen

13.7.1 Ipsen Company Information

13.7.2 Ipsen Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.7.3 Ipsen Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ipsen Main Business Overview

13.7.5 Ipsen Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.8.3 Sanofi Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Endo

13.9.1 Endo Company Information

13.9.2 Endo Luteinizing Hormone-releasing Hormone Analogs Product Offered

13.9.3 Endo Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Endo Main Business Overview

13.9.5 Endo Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Luteinizing Hormone-releasing Hormone Analogs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Luteinizing Hormone-releasing Hormone Analogs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Leuprorelin

Table 4. Major Players of Goserelin

Table 5. Major Players of Taltirelin

Table 6. Major Players of Histrelin

Table 7. Major Players of Other

Table 8. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)

Table 9. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

Table 10. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Type (2017-2022)

Table 12. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)

Table 14. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Table 15. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Application (2017-2022)

Table 16. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Application (2017-2022)

Table 17. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Company (2020-2022) & (K Units)

Table 19. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Company (2020-2022)

Table 20. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company (2020-2022)

Table 22. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Producing Area Distribution and Sales Area

Table 24. Players Luteinizing Hormone-releasing Hormone Analogs Products Offered

Table 25. Luteinizing Hormone-releasing Hormone Analogs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)

Table 38. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)

Table 40. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

Table 42. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Table 44. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region (2017-2022)

Table 46. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Region (2017-2022)

Table 48. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

Table 50. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Table 52. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)

Table 54. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)

Table 56. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

Table 58. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Luteinizing Hormone-releasing Hormone Analogs

Table 69. Key Market Challenges & Risks of Luteinizing Hormone-releasing Hormone Analogs

Table 70. Key Industry Trends of Luteinizing Hormone-releasing Hormone Analogs

Table 71. Luteinizing Hormone-releasing Hormone Analogs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Luteinizing Hormone-releasing Hormone Analogs Distributors List

Table 74. Luteinizing Hormone-releasing Hormone Analogs Customer List

Table 75. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Forecast by Region

Table 77. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Application (2023-2028)

Table 95. AbbVie Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 96. AbbVie Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 97. AbbVie Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. AbbVie Main Business

Table 99. AbbVie Latest Developments

Table 100. AstraZeneca Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 101. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 102. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. AstraZeneca Main Business

Table 104. AstraZeneca Latest Developments

Table 105. Ferring Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 106. Ferring Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 107. Ferring Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Ferring Main Business

Table 109. Ferring Latest Developments

Table 110. TerSera Therapeutics Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 111. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 112. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. TerSera Therapeutics Main Business

Table 114. TerSera Therapeutics Latest Developments

Table 115. Takeda Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 116. Takeda Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 117. Takeda Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Takeda Main Business

Table 119. Takeda Latest Developments

Table 120. LIVZON Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 121. LIVZON Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 122. LIVZON Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. LIVZON Main Business

Table 124. LIVZON Latest Developments

Table 125. Ipsen Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 126. Ipsen Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 127. Ipsen Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Ipsen Main Business

Table 129. Ipsen Latest Developments

Table 130. Sanofi Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 131. Sanofi Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 132. Sanofi Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Sanofi Main Business

Table 134. Sanofi Latest Developments

Table 135. Endo Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors

Table 136. Endo Luteinizing Hormone-releasing Hormone Analogs Product Offered

Table 137. Endo Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Endo Main Business

Table 139. Endo Latest Developments

List of Figures

Figure 1. Picture of Luteinizing Hormone-releasing Hormone Analogs

Figure 2. Luteinizing Hormone-releasing Hormone Analogs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Luteinizing Hormone-releasing Hormone Analogs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Leuprorelin

Figure 10. Product Picture of Goserelin

Figure 11. Product Picture of Taltirelin

Figure 12. Product Picture of Histrelin

Figure 13. Product Picture of Other

Figure 14. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type in 2021

Figure 15. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Type (2017-2022)

Figure 16. Luteinizing Hormone-releasing Hormone Analogs Consumed in Hospital

Figure 17. Global Luteinizing Hormone-releasing Hormone Analogs Market: Hospital (2017-2022) & (K Units)

Figure 18. Luteinizing Hormone-releasing Hormone Analogs Consumed in Pharmacy

Figure 19. Global Luteinizing Hormone-releasing Hormone Analogs Market: Pharmacy (2017-2022) & (K Units)

Figure 20. Luteinizing Hormone-releasing Hormone Analogs Consumed in Other

Figure 21. Global Luteinizing Hormone-releasing Hormone Analogs Market: Other (2017-2022) & (K Units)

Figure 22. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)

Figure 23. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Application in 2021

Figure 24. Luteinizing Hormone-releasing Hormone Analogs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company in 2021

Figure 26. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Geographic Region in 2021

Figure 28. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region (2017-2022)

Figure 29. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country/Region in 2021

Figure 30. Americas Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)

Figure 31. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)

Figure 32. APAC Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)

Figure 33. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)

Figure 34. Europe Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)

Figure 35. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)

Figure 38. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021

Figure 39. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021

Figure 40. United States Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region in 2021

Figure 45. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Regions in 2021

Figure 46. China Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021

Figure 53. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021

Figure 54. Germany Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021

Figure 61. Egypt Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Luteinizing Hormone-releasing Hormone Analogs in 2021

Figure 67. Manufacturing Process Analysis of Luteinizing Hormone-releasing Hormone Analogs

Figure 68. Industry Chain Structure of Luteinizing Hormone-releasing Hormone Analogs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390